Healthcare DIVE January 14, 2020
The chief executives of two competing managed care firms kicked off the J.P. Morgan Healthcare Conference on Monday addressing a similar theme, arguing the case their company is posed to unlock more long-term organic growth.
JPM’s annual conference in San Francisco, one of the industry’s most influential, features some of the nation’s largest nonprofit health systems, pharmaceutical firms and insurers, including rivals Centene and Molina.
The leader of Long Beach, California-based Molina was clear about strategy moving forward. The payer will use its $1.7 billion in excess capital to reinvest in the company, honing in on three areas: organic growth, inorganic growth through bolt-on acquisitions and share repurchasing.
“I’ll repeat this countless numbers of times this afternoon: Our first priority...